Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shrini Industries is a pharmaceutical manufacturing company based in Hyderabad, India, specializing in the production of Active Pharmaceutical Ingredients (APIs) and drug intermediates. The company is primarily recognized for its expertise in the development and large-scale synthesis of proton pump inhibitors (PPIs), including Omeprazole, Pantoprazole, and Lansoprazole. Shrini Industries serves as a contract manufacturing partner for various global pharmaceutical firms, providing high-quality chemical components for gastrointestinal medications. Their facilities are designed to meet international regulatory standards, ensuring the delivery of reliable and cost-effective pharmaceutical solutions. With a focus on process chemistry and quality control, the company has established itself as a key supplier in the global generic drug supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shrini Industries.